Primary chemotherapy for operable breast cancer: the NSABP experience

被引:0
作者
HD Bear
机构
[1] Virginia Commonwealth University,Division of Surgical Oncology and the Massey Cancer Center
来源
Breast Cancer Research | / 7卷
关键词
Overall Survival; Docetaxel; Preoperative Chemotherapy; Pathologic Complete Response; Operable Breast Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 15 条
[1]  
Fisher B(1997)Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 2483-2493
[2]  
Brown A(2001)Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 JNCI Mongraphs 30 96-102
[3]  
Mamounas E(1998)Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 2672-2685
[4]  
Wolmark N(2003)The effect on tumor response of adding sequential preoperative docetaxel (Tax-otere) to preoperative doxorubicin and cyclophosphamide (AC): preliminary results from National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-27 J Clin Oncol 21 4165-4174
[5]  
Wang J(2004)A randomized trial comparing preoperative (preop) doxorubicin/cyclophosphamide (AC) to preop AC followed by preop docetaxel and to preop AC followed by postoperative docetaxel in patients with operable carcinoma of the breast: results of NSABP B-27 [abstract] Breast Cancer Res Treat 88 S16-undefined
[6]  
Mamounas E(undefined)undefined undefined undefined undefined-undefined
[7]  
Fisher B(undefined)undefined undefined undefined undefined-undefined
[8]  
Bryant J(undefined)undefined undefined undefined undefined-undefined
[9]  
Wolmark N(undefined)undefined undefined undefined undefined-undefined
[10]  
Bear HD(undefined)undefined undefined undefined undefined-undefined